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It’s never easy to make a move from
one side of the US to the other, but
Tim Mitchison did it recently with a
new baby in one arm and a newly
jealous dog in the other. Mitchison
has left the University of California,
San Francisco (UCSF), where he
worked for the past ten years on how
microtubules behave, make spindles,
and move chromosomes, to be the
co-director of a new Institute
attached to Harvard Medical School,
the Institute for Chemistry and Cell
Biology (ICCB).
Mitchison brings with him a
reputation for great science, raucous
parties and fishnet stockings on
Halloween. The move brings him into
an environment where he can fully
apply the power of chemical synthesis
to the solution of cell biological
problems. If Bostonians are lucky, he
will also bring along the fishnets.
“I always knew I wanted to be a
scientist, certainly by the age of six
or seven,” says Mitchison. “Science
was definitely a family business.”
Mitchison’s father, Avrion, was a
noted immunologist working on
transplantation immunity (which at
the time was “totally opaque . . .
absolutely mystifying”), his Uncle
Murdoch was a yeast physiologist
who trained Paul Nurse and Kim
Nasmyth, among others, and his
great-uncle was the evolutionary
biologist J.B.S. Haldane.
Mitchison started at Oxford and
then moved to UCSF in 1979, first as
a technician and then for his PhD.
He toyed with the idea of working
on tumor virology with Michael
Bishop, but a series of lectures by
Marc Kirschner on timing and spatial
organization in cells turned him on to
microtubules. “The ideas were
pretty mind-blowing,” says
Mitchison. “He was taking problems
that epitomize biology, that make
living systems alive, and saying that
now the time was ripe to understand
these at a molecular level.”
The first step for Mitchison was
purification of centrosomes, the
structures that direct microtubule
growth and form the poles of the
mitotic spindle in eukaryotic cells.
While studying these isolated
complexes, he noticed that reducing
the concentration of tubulin (the
subunit of microtubules) did not
result in a uniform reduction in the
rate of microtubule growth. Some
microtubules continued to grow
rapidly, while many more underwent
a “catastrophic” conversion to a
rapid shortening phase. The net
result — the only parameter that
other workers had looked at — was
less polymerization.
Mitchison first suggested the
term ‘microtubule jerking’ to
describe the alternate stable states of
growing and shrinking, but gratefully
accepted Kirschner’s suggestion of
‘dynamic instability’. When
Mitchison first presented the idea of
dynamic instability at a meeting,
“the microtubule mafia were totally
surprised and didn’t really believe
it,” he says. But after initial
scepticism, the model was embraced
by cell biologists. “It allowed people
to see how plastic the system was,
and how the cell could control
microtubule arrays,” says Conly
Rieder of the Wadsworth Center in
Albany, New York.
After brief interludes as a post-
doc in the Kirschner lab and as a
research fellow at the National
Institute for Medical Research in
Mill Hill, London, Mitchison started
as an assistant professor at UCSF in
the late 1980s. He remembers the
lab as an exciting, lively place,
“People were really sparring with
each other to do their best work.”
Mitchison had just shown that
microtubule attachment to the
chromosome (at a site called the
kinetochore) is dynamic, with tubulin
subunits constantly coming and going.
To further prove this point he made a
‘caged’ version of the fluorescent dye
fluorescein. When this new
compound was linked to tubulin and
added to cells, it was incorporated into
microtubules but did not fluoresce. A
bar of light on the spindle, however,
knocked off a chemical group from
the caged molecule and gave a stripe
across the microtubules that
Mitchison could track as it moved
steadily away from the kinetochore
and towards the spindle pole.
Repeating this experiment with
actin, a student then showed that
actin remains fixed relative to the
underlying substrate as cells move.
Mitchison now uses the intracellular
motility of the pathogenic
microorganism Listeria as a model for
studying eukaryotic cell motility, and
has recently isolated proteins
involved in this process.
Studies of chromosome
movement began when a student in
the lab isolated eukaryotic
chromosomes, then showed that they
can move in opposite directions
along microtubules, depending on
the amount of phosphorylation of the
kinetochore. Others in the lab have
used frog extracts to isolate proteins
involved in spindle formation, other
proteins involved in the change in
microtubule dynamics in mitosis, and
R666 Current Biology, Vol 7 No 11
Changing time. Tim Mitchison with his new
daughter Lorna Mei.
even in chromosome condensation.
“Everything he touches he leaves a
big impact on,” says Rieder.
Mitchison is conscious of his shift
from describing phenomena to
identifying specific proteins that do
the work. He is perhaps more keen
on the ‘how’ than the ‘what’, but says
he does “want to get to the level of
molecular mechanism.”
This is part of the reason for his
shift to the ICCB. Once he has a
protein, he wants to define its
function by switching it on and off at
will. “This is the major stumbling
block in modern cell biology,” he
says. “The high road is biochemical
reconstitution [combining all
necessary components in a test
tube]. For Listeria and actin I think
we can do that soon, but mitosis is
too complicated at the moment. In
the next few years we will probably
have to be satisfied with
reconstitution of simple sub-
processes in mitosis.” Genetics has
its limitations, and methods such as
antisense are far from perfect; the
solution, says Mitchison, is specific
chemical inhibitors.
The new ICCB will involve
approximately equal numbers of
chemists and biologists, including
Stuart Schreiber, the other
co-director, and researchers affiliated
with other Harvard and Harvard
Medical School faculties. Harvard
has provided 10,000 square feet of
space, start-up funds, and a new
professorship for Mitchison. He will
search large libraries of chemicals for
inhibitors of both specific proteins
and specific cell biological processes.
There will be distractions at the
start: the unloading of packing cases,
the changing of diapers, and perhaps
the reconstruction of the “love
shack” in the back garden, complete
with makeshift hot tub (a bath with a
Coleman stove underneath). But,
with chemistry at his disposal,
Mitchison will be in a position to pull
apart mitosis, movement and more.
William Wells is a freelance writer based in
San Francisco, USA.
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What is it famous for?  To put it
bluntly, Brown and Goldstein.
Michael Brown and Joseph
Goldstein shared the Nobel prize in
physiology or medicine in 1985 for
their discovery of the basic
mechanisms of cholesterol
metabolism. In fact, UT
Southwestern in Dallas has now
attracted a plethora of shining lights
in biomedicine, but Brown and
Goldstein were among the earliest
recruits and the first to make it big.
When did they move there?  Goldstein
was a homegrown talent (his
down-home accent is well known on
the lecture circuit) who returned to
his alma mater in 1972. Around the
same time, he persuaded Brown
that this obscure southern medical
school was going places, and the
two have been working there ever
since. Last month, a special Cell
Biology and Genetic Diseases
Symposium to celebrate the pair’s
25 years at UT Southwestern
attracted a heavyweight line-up of
speakers, including this year’s
Nobel Prize-winner Stanley
Prusiner.
Is UT Southwestern in the major
league?  Although its Ivy League
brethren may look down their noses
at UT Southwestern, a 1994 study
measuring the research impact of US
universities placed it among the top
eight institutions in the country. It
boasts more Nobel laureates than
any other medical school in the
world, with Johann Deisenhofer
(1988 chemistry prize, for X-ray
crystallography) and Alfred Gilman
(1994 prize for physiology or
medicine, for the discovery of G
proteins) making up the quartet.
The Center has 1000 faculty
members and trains 3100 students a
year.
How did it rise from obscurity?  Mainly
through the determination of Donald
Seldin, its gritty and inspirational
Chair of Internal Medicine for 35
years. When Seldin arrived there
from Yale in 1951, he found a
collection of dilapidated army shacks
on a street corner in downtown
Dallas. With a commitment to basic
science, Seldin set about attracting
young talent, but he was hampered
in the early years by the lack of funds
and a lack of air conditioning.
Undaunted, he decided the medical
school could grow its own, and
started a highly successful mentoring
program that nurtured the best and
the brightest.
How is it funded?  During the
Center’s first major wave of
expansion in the 1970s, Seldin rode
the Texas boom, using generous
State funding to attract big names to
the wide open spaces of UT
Southwestern. But when the oil
price dropped in the 1980s, so did
the funding base. The gap was
plugged with spectacular success by
the new UT President, Kern
Wildenthal. He netted sizeable gifts
from several private donors, most
famous among them the former US
presidential candidate Ross Perot,
who gave $20 million in 1988, and
another $23.3 million last year. Now,
more than half the Center’s
operating funds ($429.6 million in
1995) come from non-government
sources, giving the Center an
enviable independence.
What’s it like to work there?  The
quality of its buildings has grown in
direct proportion to its finances. The
Medical Center is expanding into a
whole new section of the campus,
and planning is well under way for at
least six new research towers. But it
may still be hard work to persuade
East- and West-Coast scientists that
Dallas is the place to be.
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